Skip to Content

Clinical Trial Details

Whole Brain Radiation Therapy and Lapatinib

Randomized Trial of Whole Brain Radiation Therapy and Lapatinib in Patients with Brain Metastasis from Her2 – Positive Breast Cancer

IRB Protocol Number
RTOG 1119
Principal Investigator(s)
Tom Sheldon, MD

Clinical Trial Categories

  • Breast Cancer
National Cancer Institute
How to Participate

Inclusion Criteria:

  • Breast cancer must be Her2 positive;
  • Must have at least 1 measureable cancer area on the brain;
  • Must be able to care for most of their own needs;
  • Must be able to swallow and retain oral medication.

Exclusion Criteria:

  • Must not have had chemotherapy within 14 days of enrollment.


  • Breast Care Center
    248 Pleasant Street
    Pillsbury Building, Suite 206
    Concord, NH 03301
    Main: 603-230-7266
  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6000